Epithelial-specific methylation marker: A potential plasma biomarker in advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 11, 2011, Pages 1818-1825

  Vinayanuwattikun, Chanida ^a,b   Sriuranpong, Virote ^b   Tanasanvimon, Suebpong ^b   Chantranuwat, Poonchavist ^a   Mutirangura, Apiwat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Biomarker; Epithelial specific methylation marker; Lung cancer; Methylation; SHP 1

Indexed keywords

BIOLOGICAL MARKER; NUCLEIC ACID; PROTEIN TYROSINE PHOSPHATASE SHP 1; SHP 1 PROMOTER 2 PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CELL SPECIFICITY; CONTROLLED STUDY; EPITHELIUM CELL; EPITHELIUM TUMOR; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 80054924531     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318226b46f     Document Type: Article

References (25)

1. Butt AN, Swaminathan R. Overview of circulating nucleic acids in plasma/serum. Ann NY Acad Sci 2008;1137:236-242.
2. Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-650. (Pubitemid 8051621)
3. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007;39:197-207. (Pubitemid 46439650)
4. Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 1998;4:665-669. (Pubitemid 28193566)
5. Chan KC, Leung SF, Yeung SW, et al. Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients. Clin Cancer Res 2008;14: 4141-4145.
6. Leung SF, Zee B, Ma BB, et al. Plasma Epstein-Barr viral deoxyribo-nucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol 2006;24: 5414-5418. (Pubitemid 46623174)
7. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-2470. (Pubitemid 38736543)
8. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-375. (Pubitemid 34106406)
9. Esteller M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70. (Pubitemid 29062958)
10. Hsu HS, Chen TP, Hung CH, et al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 2007;110:2019-2026.
11. Gautschi O, Bigosch C, Huegli B, et al. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004;22:4157-4164. (Pubitemid 41185186)
12. Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001;61:4675-4678. (Pubitemid 32691874)
13. Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-3908. (Pubitemid 46606202)
14. Andriani F, Conte D, Mastrangelo T, et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J cancer 2004;108: 91-96. (Pubitemid 37444449)
15. Banville D, Stocco R, Shen SH. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts. Genomics 1995;27:165-173.
16. Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, et al. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 2006;84:175-182. (Pubitemid 43201258)
17. Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002;48:421-427. (Pubitemid 34174575)
18. de Maat MF, Umetani N, Sunami E, et al. Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles. Mol Cancer Res 2007;5:461-471. (Pubitemid 46903955)
19. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-98. (Pubitemid 34438899)
20. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355: 2542-2550. (Pubitemid 44917502)
21. Launay JM, Del Pino M, Chironi G, et al. Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 2009;4:e7959.
22. Liu F, Killian JK, Yang M, et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29:3650-3664.
23. Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-322. (Pubitemid 19216753)
24. Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999;18:65-73. (Pubitemid 29411092)
25. Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003;103:149-152. (Pubitemid 35461505)